AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

AMRI Introduces Protein Expression & Purification Solutions

 Uncategorized  Comments Off on AMRI Introduces Protein Expression & Purification Solutions
Sep 052014
 

 

 

https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR5DW-rAfgA3NSOdcdlSQf1aq2Ov4-z_jkRRHmqdsvN-RFRlccRWw

A MESSAGE FROM MICHAEL A. LUTHER, SENIOR VICE PRESIDENT DISCOVERY AND DEVELOPMENT
Dear Anthony,As a company with a deep history of discovery innovation, Albany Molecular Research Inc. (AMRI) continues to explore scientific solutions that provide our customers with enhanced flexibility and access to state-of-the-art science and technologies. As part of our aim to provide you with high-value services in the area of biology and pharmacology, today we announced new platforms that enhance our discovery biology offerings.One of our new platforms comprises IND-enabling support services, which are aimed at supporting the successful initiation and completion of customer Investigational New Drug (IND) programs. As part of this offering we now provide in vitro DMPK studies, related to drug-drug interactions and metabolism, which are routinely included in IND submissions. Our Drug Metabolism and Pharmacokinetics (DMPK) group provides in vitro DMPK and bioanalytical/PK services as part of our Drug Discovery and Development Solutions (DDS) business. These services span all stages of drug discovery including exploratory, hit-to-lead, lead optimization and candidate selection, as well as the pre-clinical IND-enabling stage.

More recently, we have expanded into the protein market with an initial focus on protein expression and purification. As part of a public-private pharmaceutical research and development initiative in Buffalo, N.Y., our current and ongoing activities encompass the production of purified recombinant proteins as reagents and tools for biological assays and sterile, pyrogen-free materials for proof-of-concept, non-human in vivo studies. We are very excited to be able to offer these expanded biology services as we continue to seek innovative ways to provide relevant drug discovery services and expertise to academia and the global Bio-Pharmaceutical industry from early discovery to candidate selection and beyond.

Our goal is to leverage our deep expertise to provide you with high quality and innovative scientific solutions that drive your pipeline and portfolio. As always, if you have questions about any of the services we can provide, please contact us to request a quote so we can discuss your needs.

Sincerely,

Michael A. Luther, Ph.D., MBA
Senior Vice President, Discovery and Development
Albany Molecular Research Inc. (AMRI)
Albany Molecular Research Inc. (AMRI)
26 Corporate Circle
Albany, NY 12203

 

 

 

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: